REBUS MEDICAL LTD

REBUS MEDICAL LTD

REBUS MEDICAL LTD - Company Information

Print Friendly Version

REBUS MEDICAL LTD

Company Registration Number:
11667375 (England and Wales)

Unaudited abridged accounts for the year ended 31 March 2023

Period of accounts

Start date: 01 April 2022

End date: 31 March 2023

REBUS MEDICAL LTD

Contents of the Financial Statements

for the Period Ended 31 March 2023

Balance sheet
Notes

REBUS MEDICAL LTD

Balance sheet

As at 31 March 2023


Notes
2023
2022


£
£
Fixed assets
Tangible assets: 3 15,924 14,911
Total fixed assets: 15,924 14,911
Current assets
Debtors:   299,311 147,093
Cash at bank and in hand: 702,104 557,578
Total current assets: 1,001,415 704,671
Creditors: amounts falling due within one year:   (367,910) (314,338)
Net current assets (liabilities): 633,505 390,333
Total assets less current liabilities: 649,429 405,244
Provision for liabilities: (3,981) (2,833)
Total net assets (liabilities): 645,448 402,411
Capital and reserves
Called up share capital: 100 100
Profit and loss account: 645,348 402,311
Shareholders funds: 645,448 402,411

The notes form part of these financial statements

REBUS MEDICAL LTD

Balance sheet statements

For the year ending 31 March 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 18 July 2023
and signed on behalf of the board by:

Name: I.C. Culverhouse
Status: Director

The notes form part of these financial statements

REBUS MEDICAL LTD

Notes to the Financial Statements

for the Period Ended 31 March 2023

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

REBUS MEDICAL LTD

Notes to the Financial Statements

for the Period Ended 31 March 2023

2. Employees

2023 2022
Average number of employees during the period 14 11

REBUS MEDICAL LTD

Notes to the Financial Statements

for the Period Ended 31 March 2023

3. Tangible Assets

Total
Cost £
At 01 April 2022 23,007
Additions 6,321
At 31 March 2023 29,328
Depreciation
At 01 April 2022 8,096
Charge for year 5,308
At 31 March 2023 13,404
Net book value
At 31 March 2023 15,924
At 31 March 2022 14,911